1-9 of 9
Miaomiao Cao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting FXR in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk

Open Access
Bolin Li, Heze Fan, Hao Wu, Yiqiong Zhang, Ning Ding, Peining Liu, Qi Wang, Miaomiao Cao, Zixuan Meng, Xinxin Feng, Xiaozhen Zhuo, Wei Wu, Ying Xiong, Kai Deng, Ting Li, Junhui Liu, Yue Wu
Journal: Blood
Blood (2025) 146 (20): 2464–2478.
https://doi.org/10.1182/blood.2024027772
Published: 2025
Includes: Supplemental data
Journal Articles

Genomic heterogeneity and prognostic implications in CAR-t-treated relapsed/refractory primary CNS lymphoma

Free
Miaomiao Cao, Hui Shi, Danyang Li, Rui Liu, Zhonghua Fu, Fan Yang, Lixia Ma, Yuelu Guo, Biping Deng, Alex H. Zhang, Qinlong Zheng, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5489.
https://doi.org/10.1182/blood-2025-5489
Published: 2025
Journal Articles

Short-course glofitamab enables effective bridging to CAR-t therapy in B-NHL

Free
Rui Liu, Zhonghua Fu, Fan Yang, Lixia Ma, Miaomiao Cao, Yuelu Guo, Danyang Li, Biping Deng, Qinlong Zheng, Alex H. Zhang, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7259.
https://doi.org/10.1182/blood-2025-7259
Published: 2025
Journal Articles

CAR-t cell therapy in TP53-mutated CNS lymphoma: Overcoming a high-risk genetic barrier

Free
Danyang Li, Rui Liu, Zhonghua Fu, Fan Yang, Lixia Ma, Miaomiao Cao, Yuelu Guo, Biping Deng, Alex H. Zhang, Qinlong Zheng, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3708.
https://doi.org/10.1182/blood-2025-3708
Published: 2025
Journal Articles

Impact of TP53 mutations on survival outcomes in the CAR-t era of large b-cell lymphoma

Free
Rui Liu, Danyang Li, Zhonghua Fu, Fan Yang, Miaomiao Cao, Lixia Ma, Yuelu Guo, Alex H. Zhang, Biping Deng, Qinlong Zheng, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3706.
https://doi.org/10.1182/blood-2025-3706
Published: 2025
Journal Articles

Prospective phase I/II study of CD19-directed CAR-t therapy in relapsed/refractory central nervous system lymphoma: Clinical outcomes and safety profile

Free
Danyang Li, Rui Liu, Zhonghua Fu, Fan Yang, Lixia Ma, Miaomiao Cao, Yuelu Guo, Biping Deng, Alex H. Zhang, Qinlong Zheng, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 672.
https://doi.org/10.1182/blood-2025-672
Published: 2025
Journal Articles

Transplantation in combination with CAR T-cell therapy for refractory/relapsed aggressive B-cell lymphoma after failure of CD19 CAR-T cell therapy

Free
Fan Yang, Rui Liu, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Haifeng Wu, Alex H. Zhang, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5484.
https://doi.org/10.1182/blood-2025-5484
Published: 2025
Journal Articles

The ratio of post-infusion circulating PD-1+ CAR-T subsets to product PD-1+ CAR-T cells serves as a predictive biomarker for long-term disease control in CAR T-cell therapy for R/R B-cell lymphoma

Free
Fan Yang, Rui Liu, Zhonghua Fu, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Shilin Gan, Alex H. Zhang, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2377.
https://doi.org/10.1182/blood-2025-2377
Published: 2025
Journal Articles

CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: Single-arm, open-label, phase I study

Free
Fan Yang, Rui Liu, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Haifeng Wu, Alex H. Zhang, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2368.
https://doi.org/10.1182/blood-2025-2368
Published: 2025